| scholarly article | Q13442814 |
| P50 | author | Urban Lendahl | Q5946139 |
| P2093 | author name string | Collins VP | |
| Dahlstrand J | |||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nervous system | Q9404 |
| P304 | page(s) | 5334-5341 | |
| P577 | publication date | 1992-10-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Expression of the class VI intermediate filament nestin in human central nervous system tumors | |
| P478 | volume | 52 |
| Q27304385 | A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1 |
| Q35102188 | A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death |
| Q40931057 | A novel human astrocyte cell line (A735) with astrocyte-specific neurotransmitter function |
| Q34635517 | A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1. |
| Q57050488 | A systems-approach reveals human nestin is an endothelial-enriched, angiogenesis-independent intermediate filament protein |
| Q34773218 | A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markers |
| Q36585556 | APC binds intermediate filaments and is required for their reorganization during cell migration. |
| Q41782223 | Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin |
| Q33945989 | Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation. |
| Q38920264 | Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids |
| Q39680687 | Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity |
| Q39588266 | Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors |
| Q39117664 | Antiproliferative effects of PACAP and VIP in serum-starved glioma cells |
| Q41244919 | Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo |
| Q37627436 | Brain cancer propagating cells: biology, genetics and targeted therapies |
| Q42576930 | Brain cancer stem cells: current status on glioblastoma multiforme |
| Q37773191 | Brain tumor stem cells as therapeutic targets in models of glioma |
| Q36740051 | Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells |
| Q55463554 | CD133+ niches and single cells in glioblastoma have different phenotypes. |
| Q34516701 | Cancer stem cells: the final frontier for glioma virotherapy. |
| Q34028947 | Clinical value of CD133 and nestin in patients with glioma: a population-based study |
| Q35577863 | Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma |
| Q35679482 | Depletion of intermediate filament protein Nestin, a target of microRNA-940, suppresses tumorigenesis by inducing spontaneous DNA damage accumulation in human nasopharyngeal carcinoma |
| Q35559877 | Design and application of oncolytic HSV vectors for glioblastoma therapy |
| Q37164106 | Development of a novel mouse glioma model using lentiviral vectors |
| Q36021554 | Developmental neurobiology and the origin of brain tumors |
| Q48832736 | Different pattern of expression of nestin in the non-specific form of dysembryoplastic neuroepithelial tumors compared to the simple and complex forms |
| Q37134462 | Different transcription factors regulate nestin gene expression during P19 cell neural differentiation and central nervous system development |
| Q35753454 | Effects of growth factors and basement membrane proteins on the phenotype of U-373 MG glioblastoma cells as determined by the expression of intermediate filament proteins |
| Q27333230 | Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model |
| Q90099858 | Experimental models and tools to tackle glioblastoma |
| Q36640667 | Expression and role of nestin in human cervical intraepithelial neoplasia and cervical cancer |
| Q54303368 | Expression of nestin, mesothelin and epithelial membrane antigen (EMA) in developing and adult human meninges and meningiomas |
| Q35746422 | Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal |
| Q36129204 | Feline bone marrow-derived mesenchymal stromal cells (MSCs) show similar phenotype and functions with regards to neuronal differentiation as human MSCs |
| Q48872737 | Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-hydroxydopamine-lesioned rats gives rise to grafts rich in dopaminergic neurons. |
| Q46087519 | Flow cytometry analysis of neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy |
| Q41827902 | Forebrain overexpression of alpha-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption |
| Q36328555 | Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. |
| Q38816630 | Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest |
| Q36015831 | Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype |
| Q55463938 | Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation. |
| Q48428390 | Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells |
| Q48145447 | Hepatic stellate cells derived from the nestin-positive cells in septum transversum during rat liver development. |
| Q22008708 | Heterogeneity of neural progenitor cells revealed by enhancers in the nestin gene |
| Q55030657 | Heterogenic expression of stem cell markers in patient-derived glioblastoma spheroid cultures exposed to long-term hypoxia. |
| Q35077834 | High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas |
| Q49262902 | Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug |
| Q59131896 | Immunohistochemical characterization of stem cell and differentiation markers of the dental pulp of human natal teeth |
| Q33393203 | Immuolocalization of nestin in pancreatic tissue of mice at different ages |
| Q41349171 | Intermediate filaments in the nervous system: implications in cancer |
| Q46911549 | Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. |
| Q28083277 | MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown |
| Q24679327 | Molecular evolution of type VI intermediate filament proteins |
| Q38696948 | Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis |
| Q28511452 | Nestin Is Required for the Proper Self-Renewal of Neural Stem Cells |
| Q37124679 | Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer |
| Q42208891 | Nestin expression in embryonic and adult human teeth under normal and pathological conditions |
| Q35769858 | Nestin expression in odontoblasts and odontogenic ectomesenchymal tissue of odontogenic tumours |
| Q33377272 | Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines |
| Q48476888 | Nestin expression in reactive astrocytes of human pathology. |
| Q25255381 | Nestin expression in the cell lines derived from glioblastoma multiforme. |
| Q37057915 | Nestin in central nervous system cells |
| Q34521363 | Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis |
| Q33559656 | Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder |
| Q46660136 | Nestin regulates proliferation and invasion of gastrointestinal stromal tumor cells by altering mitochondrial dynamics |
| Q28973624 | Nestin-expressing cells in the gut give rise to enteric neurons and glial cells |
| Q40226917 | Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls |
| Q37230949 | Origins and clinical implications of the brain tumor stem cell hypothesis |
| Q35221830 | Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model. |
| Q34334516 | Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors |
| Q33729734 | Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link? |
| Q42952983 | Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury |
| Q50681426 | Regulation of the intermediate filament protein nestin at rodent neuromuscular junctions by innervation and activity. |
| Q34768932 | Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis |
| Q47104368 | SOX10-MITF pathway activity in melanoma cells. |
| Q34005547 | Sox proteins in melanocyte development and melanoma |
| Q42857232 | Specific and innervation-regulated expression of the intermediate filament protein nestin at neuromuscular and myotendinous junctions in skeletal muscle |
| Q27333067 | Spinal cord injury reveals multilineage differentiation of ependymal cells |
| Q37169144 | Stem cell markers in gliomas |
| Q38160452 | Stem cells and the origin of gliomas: A historical reappraisal with molecular advancements. |
| Q37415871 | Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme |
| Q43239168 | Targeting metabolism to induce cell death in cancer cells and cancer stem cells |
| Q35858416 | The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes. |
| Q92757181 | The Role of SVZ Stem Cells in Glioblastoma |
| Q36854372 | The cancer stem cell paradigm: a new understanding of tumor development and treatment |
| Q34008284 | The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature |
| Q40923830 | The neuroepithelial stem cell concept: implications for neuro-oncology |
| Q27005807 | The potential origin of glioblastoma initiating cells |
| Q36926655 | The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group |
| Q37402364 | The role of CD133+ cells in a recurrent embryonal tumor with abundant neuropil and true rosettes (ETANTR). |
| Q33937611 | The top cited articles on glioma stem cells in Web of Science |
| Q34694093 | Transdifferentiation of glioblastoma cells into vascular endothelial cells |
| Q35069499 | Tumor versus stromal cells in culture--survival of the fittest? |
| Q39922260 | Tumor-specific activity of cellular regulatory elements is down-regulated upon insertion into the herpes simplex virus genome |
| Q40453240 | Up-regulation of neuropoiesis generating glial progenitors that infiltrate rat intracranial glioma. |
| Q38081776 | What is the clinical value of cancer stem cell markers in gliomas? |
| Q47133782 | lncTCF7 is a negative prognostic factor, and knockdown of lncTCF7 inhibits migration, proliferation and tumorigenicity in glioma |
Search more.